IBD Therapeutics discloses TRPM8 and TrpV1 antagonists/opioid receptor agonists Dec. 2, 2019 No Comments
New pan alphav antagonist with excellent oral PK properties and bioavailability for IPF treatment Nov. 25, 2019 No Comments
Discovery of targetable dopamine receptor controlling childhood-onset asthma Nov. 25, 2019 No Comments
Novel potent OXE receptor antagonists with prolonged plasma lifetime for eosinophilic diseases Nov. 20, 2019 No Comments
resTORbio stops development of RTB-101 for clinically symptomatic respiratory illness Nov. 15, 2019 No Comments
RSS